{Reference Type}: Letter
{Title}: Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis.
{Author}: Khattabi L;
{Journal}: Med Hypotheses
{Volume}: 143
{Issue}: 0
{Year}: Oct 2020
{Factor}: 4.411
{DOI}: 10.1016/j.mehy.2020.110108
{Abstract}: The present hypothesis suggests an innovative therapeutic strategy to cease Covid 19 infection. It is based on the inhibition of Spike glycoprotein and ACE-2 receptor interaction that provides the entry of virus in human host cells, by targeting the S protein with a recombinant molecule made of the ACE-2 receptor ectodomain and an opsonin, the formed complex would enhance its phagocytosis.